Ammonia and ethylene biomarkers in the respiration of the people with schizophrenia using photoacoustic spectroscopy
暂无分享,去创建一个
[1] Cristina Popa,et al. Testing fruit quality by photoacoustic spectroscopy assay , 2014 .
[2] Fengmin Zhang,et al. Noninvasive detection of colorectal cancer by analysis of exhaled breath , 2014, Analytical and Bioanalytical Chemistry.
[3] Alin Ciobica,et al. Oxidative stress in schizophrenia - focusing on the main markers. , 2011, Psychiatria Danubina.
[4] Andrew Mooney,et al. Palliative and end-of-life care in advanced renal failure. , 2010, Clinical medicine.
[5] Michael Berk,et al. Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. , 2009, Annals of the Academy of Medicine, Singapore.
[6] Xiang Yang Zhang,et al. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial , 2006, Psychopharmacology.
[7] C. Fendri,et al. Implication du stress oxydant dans la physiopathologie de la schizophrénie: revue de la littérature. , 2006 .
[8] S A Cohen,et al. Risperidone for Aggression and Self-Injurious Behavior in Adults with Mental Retardation , 1998, Journal of autism and developmental disorders.
[9] Huseyin Vural,et al. Is the Arginine-Nitric Oxide Pathway Involved in the Pathogenesis of Schizophrenia? , 2003, Neuropsychobiology.
[10] Sandhya Mishra,et al. Evaluation of antioxidant deficit in schizophrenia , 2008, Indian journal of psychiatry.
[11] Karl Crowley,et al. Direct measurement of ammonia in simulated human breath using an inkjet-printed polyaniline nanoparticle sensor. , 2013, Analytica chimica acta.
[12] A Bach,et al. Nitrogen metabolism in the rumen. , 2005, Journal of dairy science.
[13] B. Chérif-Zahar,et al. NH3 is involved in the NH4+ transport induced by the functional expression of the human Rh C glycoprotein. , 2004, The Journal of biological chemistry.
[14] Joachim D Pleil,et al. Breath analysis--past, present and future: a special issue in honour of Michael Phillips' 70th birthday. , 2013, Journal of breath research.
[15] A. Puiu,et al. Stress monitoring in a Guinness 10-day scuba dive , 2007 .
[16] Brian M. Ross,et al. Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia , 2011 .
[17] Ramona Cernat,et al. Ultrasensitive CO2 laser photoacoustic system , 2010 .
[18] J. C. Tilak,et al. Free radicals and antioxidants in human health: current status and future prospects. , 2004, The Journal of the Association of Physicians of India.
[19] Cristina POPA,et al. SPECTROSCOPIC STUDIES OF ETHYLENE AND AMMONIA AS BIOMARKERS AT PATIENTS WITH DIFFERENT MEDICAL DISORDERS , 2011 .
[20] Ganesh Dakhale,et al. Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics , 2004, Neuropsychobiology.
[21] Simon Gibbons,et al. Use of Levomepromazine in the Management of Aggression in Adults with Intellectual Disability , 2008 .
[22] L. J. Barnhill,et al. Risperidone and Explosive Aggressive Autism , 1997, Journal of autism and developmental disorders.
[23] Cristina Popa,et al. Exertion in Kangoo Jumps Aerobic: Evaluation and Interpretation Using Spectroscopic Technique Determinations , 2013 .
[24] I. Altuntaş,et al. Erythrocyte Superoxide Dismutase and Glutathione Peroxidase Activities, and Malondialdehyde and Reduced Glutathione Levels in Schizophrenic Patients , 2000, Clinical chemistry and laboratory medicine.
[25] Andrew M Ellis,et al. Real-time multi-marker measurement of organic compounds in human breath: towards fingerprinting breath , 2013, Journal of breath research.
[26] Natalia Sidorova,et al. Smart technologies for long-term stress monitoring at work , 2013, Proceedings of the 26th IEEE International Symposium on Computer-Based Medical Systems.
[27] Pete Smith,et al. Energy crops: current status and future prospects , 2006 .
[28] L. Duggan,et al. Antipsychotic medication for challenging behaviour in people with learning disability. , 2004, The Cochrane database of systematic reviews.
[29] Ian H. Treasaden,et al. Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia , 2010, Annals of General Psychiatry.
[30] R. Dweik,et al. Exhaled breath analysis: the new frontier in medical testing , 2008, Journal of breath research.
[31] G. Chazot,et al. Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[32] M. Campbell-Thompson,et al. Expression of the ammonia transporter proteins Rh B glycoprotein and Rh C glycoprotein in the intestinal tract. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[33] A Dietrich-Muszalska,et al. Oxidative stress in blood platelets from schizophrenic patients , 2005, Platelets.
[34] J. Verlander,et al. Role of NH3 and NH4+ transporters in renal acid-base transport. , 2011, American journal of physiology. Renal physiology.
[35] V. Parikh,et al. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics , 2002, Schizophrenia Research.
[36] Benedicta D'Souza,et al. Oxidative injury and antioxidant vitamins E and C in Schizophrenia , 2008, Indian Journal of Clinical Biochemistry.
[37] I. Stojanovic,et al. Oxidative stress as marker of positive symptoms in schizophrenia , 2002 .
[38] Iztok Grabnar,et al. Oxidative Stress in Schizophrenia , 2011, Current neuropharmacology.
[39] R. Cernat,et al. Evaluation of ammonia absorption coefficients by photoacoustic spectroscopy for detection of ammonia levels in human breath , 2011 .
[40] Joachim D Pleil,et al. Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders , 2013, Journal of breath research.
[41] T. Woo,et al. Oxidative stress in schizophrenia: An integrated approach , 2011, Neuroscience & Biobehavioral Reviews.
[42] Ömer Akyol,et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[43] M. Phillips,et al. Volatile organic compounds in the breath of patients with schizophrenia. , 1995, Journal of clinical pathology.
[44] Pamela C. Champe,et al. Lippincott's Illustrated Reviews: Biochemistry , 2005 .
[45] A. Kerkeni,et al. [Oxidative stress involvement in schizophrenia pathophysiology: a review]. , 2006, L'Encephale.
[46] S R Schroeder,et al. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. , 2001, American journal of mental retardation : AJMR.
[47] Hossam Haick,et al. Breath testing: the future for digestive cancer detection , 2013, Expert review of gastroenterology & hepatology.
[48] S. Mukherjee,et al. Impaired antioxidant defense at the onset of psychosis , 1996, Schizophrenia Research.
[49] Paolo Zamboni,et al. Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.
[50] J. Thome,et al. Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis , 2004, Journal of Neural Transmission.
[51] P Boesiger,et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo , 2000, The European journal of neuroscience.
[52] H. Ponssen,et al. [Antipsychotic medication as a cause of deep hypothermia]. , 2003, Nederlands tijdschrift voor geneeskunde.
[53] J. Knight. Review: Free radicals, antioxidants, and the immune system. , 2000, Annals of clinical and laboratory science.
[54] P Sivaraman,et al. Levomepromazine for schizophrenia (Review) , 2013 .
[55] B. Halliwell,et al. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.
[56] Gwen Kennedy,et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. , 2005, Free radical biology & medicine.
[57] D. C. Dumitras,et al. Laser photoacoustic spectroscopy: principles, instrumentation, and characterization , 2007 .
[58] Benedicta D'Souza,et al. Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients , 2004, Indian Journal of Clinical Biochemistry.
[59] Serena J Counsell,et al. Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans , 2008, BMC psychiatry.
[60] H. Lal,et al. Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[61] August Zabernigg,et al. First observation of a potential non-invasive breath gas biomarker for kidney function , 2013, Journal of breath research.
[62] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[63] J. Hellings,et al. Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures. , 2002, American journal of mental retardation : AJMR.
[64] C. Shields,et al. Schizophrenia: a review. , 2007, American family physician.
[65] L. Voesenek,et al. Sensitive intracavity photoacoustic measurements with a CO2 waveguide laser , 1990 .
[66] A J Knight,et al. FREE RADICALS, ANTIOXIDANTS, AND THE IMMUNE SYSTEM , 2000 .
[67] R. Cernat,et al. Qualitative and quantitative determination of human biomarkers by laser photoacoustic spectroscopy methods , 2011 .
[68] H. Canatan,et al. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder , 2002, Cell biochemistry and function.
[69] P. Ranjekar,et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients , 2003, Psychiatry Research.
[70] Ante Bilić-Prcić,et al. Levomepromazine helps to reduce sleep problems in patients with PTSD , 2004, European Psychiatry.
[71] D. C. Dumitras,et al. The level of ethylene biomarker in the renal failure of elderly patients analyzed by photoacoustic spectroscopy , 2013 .
[72] Alin Ciobica,et al. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease , 2010, Neuroscience Letters.
[73] Michael Berk,et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[74] R. Cernat,et al. Ethylene and ammonia traces measurements from the patients’ breath with renal failure via LPAS method , 2011 .
[75] F. Tittel,et al. Recent advances of laser-spectroscopy-based techniques for applications in breath analysis , 2007, Journal of breath research.